Phathom Pharmaceuticals (PHAT) Accounts Payables: 2022-2025
Historic Accounts Payables for Phathom Pharmaceuticals (PHAT) over the last 4 years, with Sep 2025 value amounting to $1.1 million.
- Phathom Pharmaceuticals' Accounts Payables fell 84.93% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year decrease of 84.93%. This contributed to the annual value of $10.5 million for FY2024, which is 16.62% down from last year.
- As of Q3 2025, Phathom Pharmaceuticals' Accounts Payables stood at $1.1 million, which was down 73.18% from $4.0 million recorded in Q2 2025.
- Phathom Pharmaceuticals' Accounts Payables' 5-year high stood at $12.6 million during Q4 2023, with a 5-year trough of $1.1 million in Q3 2025.
- In the last 3 years, Phathom Pharmaceuticals' Accounts Payables had a median value of $7.1 million in 2024 and averaged $7.1 million.
- As far as peak fluctuations go, Phathom Pharmaceuticals' Accounts Payables spiked by 83.42% in 2024, and later crashed by 84.93% in 2025.
- Quarterly analysis of 4 years shows Phathom Pharmaceuticals' Accounts Payables stood at $10.0 million in 2022, then grew by 26.05% to $12.6 million in 2023, then dropped by 16.62% to $10.5 million in 2024, then crashed by 84.93% to $1.1 million in 2025.
- Its Accounts Payables stands at $1.1 million for Q3 2025, versus $4.0 million for Q2 2025 and $11.6 million for Q1 2025.